Ret Proto-Oncogene antibody (Extracellular Domain)
This anti-Ret Proto-Oncogene antibody is a Goat Polyclonal antibody detecting Ret Proto-Oncogene in WB, ELISA, IHC (p) and IHC (fro). Suitable for Mouse. This Primary Antibody has been cited in 2+ publications.
RET
Reactivity: Human
WB, IHC, IF, FACS, IC, LCI
Host: Rabbit
Polyclonal
unconjugated
Application Notes
ELISA: 0.5-1 μg/mL, IHC-F: 5 μg/mL, IHC-P: 10-15 μg/mL, WB: 0.1-0.2 μg/mL Optimal conditions should be determined by the investigator.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Reconstitute with PBS.
Concentration
Lot specific
Buffer
Lyophilized from PBS, pH 7.2 containing 5 % trehalose.
Handling Advice
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Storage
-80 °C
Storage Comment
Aliquot and store at -70 °C or lower.
Gay, Valenta, Herr, Paratore-Hari, Basler, Sommer: "Distinct adhesion-independent functions of β-catenin control stage-specific sensory neurogenesis and proliferation." in: BMC biology, Vol. 13, pp. 24, (2015) (PubMed).
Aron, Klein, Pham, Kramer, Wurst, Klein: "Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons." in: PLoS biology, Vol. 8, Issue 4, pp. e1000349, (2010) (PubMed).
Target
Ret Proto-Oncogene (RET)
Alternative Name
Ret
Background
The Ret proto-oncogene (c-Ret) is a receptor tyrosine kinase that functions as a multicompetent receptor complex in conjunction with other membrane-bound ligand-binding GDNF family receptors. Ligands that bind the Ret receptor include the glial cell line-derived neurotropic factor (GDNF) and its congeners neurturin, persephin and artemin. Alterations in the corresponding Ret gene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma and a congenital developmental disorder known as Hirschsprung’s disease. The Tyr905 residue located in the Ret kinase domain plays a crucial role in Ret catalytic and biological activity. Substitution of Phe for Tyr905 dramatically inhibits Ret autophosphorylation activity.